Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Cambridge Cognition Holdings plc (LSE:COG): Clinical Progress and Healthcare Growth in Focus as FTSE AIM All-Share Small-Cap Growth Stock Draws Investor Attention

• Classification: small-cap growth-style stock within the FTSE AIM All-Share or relevant London-market segment.

Ankur Sharma | 13 November 2026

Eco Animal Health Group plc (LSE:EAH): Clinical Progress and Healthcare Growth in Focus as FTSE AIM All-Share Small-Cap Growth Stock Draws Investor Attention

• Classification: small-cap growth-style stock within the FTSE AIM All-Share or relevant London-market segment.

Ankur Sharma | 13 November 2026

Eden Biosolutions PLC (LSE:EDEN): Clinical Progress and Healthcare Growth in Focus as FTSE AIM All-Share Small-Cap Growth Stock Draws Investor Attention

• Classification: small-cap growth-style stock within the FTSE AIM All-Share or relevant London-market segment.

Ankur Sharma | 13 November 2026

HemoGenyx Pharmaceuticals plc (LSE:HEMO): Clinical Progress and Healthcare Growth in Focus as London Stock Exchange Main Market Small-Cap Growth Stock Draws Investor Attention

• Classification: small-cap growth-style stock within theLondon Stock ExchangeMain Market or relevant London-market segment.

Ankur Sharma | 13 November 2026

ImmuPharma plc (LSE:IMM): Clinical Progress and Healthcare Growth in Focus as FTSE AIM All-Share Small-Cap Growth Stock Draws Investor Attention

• Classification: small-cap growth-style stock within the FTSE AIM All-Share or relevant London-market segment.

Ankur Sharma | 13 November 2026

SkinBioTherapeutics plc (LSE:SBTX): Clinical Progress and Healthcare Growth in Focus as FTSE AIM All-Share Small-Cap Growth Stock Draws Investor Attention

• Classification: small-cap growth-style stock within the FTSE AIM All-Share or relevant London-market segment.

Ankur Sharma | 13 November 2026

Agronomics (LSE:ANIC): AIM Growth Stock in Focus as Solar Foods Clears a Major EU Regulatory Milestone

• Key near-term watch: European Commission authorisation and the remaining regulatory timetable; also monitor offtake negotiations, financing and progress toward Solar Foods' Factory 02 decision.

Ankur Sharma | 13 November 2026

Allergy Therapeutics (LSE:AGY): AIM Growth Stock in Focus as Audited Results Clarify the Next Pipeline Phase

• Key near-term watch: cash runway, operating costs and funding requirements; also monitor clinical, regulatory and commercial milestones.

Ankur Sharma | 13 November 2026

Beximco Pharmaceuticals (LSE:BXP): AIM Growth Stock in Focus as Management Transition Meets Double-Digit Growth

• Key near-term watch: the effectiveness of the new management structure; also monitor new product launches, registrations and international sales.

Ankur Sharma | 13 November 2026

GSK (LSE:GSK): FTSE 100 Growth Stock in Focus After Positive Bexsero Regulatory Boost

• Key near-term watch: the final regulatory pathway and implementation of the Bexsero booster opportunity; also monitor commercial uptake, vaccine demand and additional pipeline readouts.

Ankur Sharma | 13 November 2026
Support

Hi! How can we help you today?

Loading…